The Asia Pacific non-invasive ventilation masks market was valued at US$ 433.81 million in 2023 and is expected to reach US$ 719.68 million by 2031; it is estimated to register a CAGR of 6.5% from 2023 to 2031.
Increasing Adoption of NIV Masks Drives Asia Pacific Non-Invasive Ventilation Masks Market
Noninvasive ventilation masks are becoming increasingly popular and expanding market opportunities by spurring innovation. Earlier diagnosis and treatment are being made possible by growing awareness campaigns about respiratory disorders such as COPD, sleep apnea, and others. The increased prescription and usage of NIV masks for disease management results from greater awareness among patients and healthcare professionals. Thus, emerging awareness of early diagnosis is likely to drive the adoption of NIV masks and create significant opportunities in the market.
Moreover, respiratory illnesses are becoming more common in emerging economies, particularly in Asia Pacific, Latin America, and the Middle East, due to pollution, urbanization, and lifestyle changes. The Noninvasive therapies are becoming widely known in these areas, owing to which the use of NIV masks is likely to continue to propel during the forecast period.
Asia Pacific Non-Invasive Ventilation Masks Market Overview
The Asia Pacific noninvasive ventilation masks market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share of the market in the region during the forecast period. The noninvasive ventilation masks market in Asia Pacific is growing due to the surging utilization of NIV masks for the treatment of respiratory diseases such as obstructive sleep apnea, COPD, and neuromuscular disorders prevailing in the region. This growing use of NIV masks is expected to bring opportunities for market players to penetrate into emerging countries in Asia Pacific.
Asia Pacific Non-Invasive Ventilation Masks Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Non-Invasive Ventilation Masks Market Segmentation
The Asia Pacific non-invasive ventilation masks market is categorized into product, application, end user, and country.
By product, the Asia Pacific non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the Asia Pacific non-invasive ventilation masks market share in 2023.
Reasons to Buy:
Increasing Adoption of NIV Masks Drives Asia Pacific Non-Invasive Ventilation Masks Market
Noninvasive ventilation masks are becoming increasingly popular and expanding market opportunities by spurring innovation. Earlier diagnosis and treatment are being made possible by growing awareness campaigns about respiratory disorders such as COPD, sleep apnea, and others. The increased prescription and usage of NIV masks for disease management results from greater awareness among patients and healthcare professionals. Thus, emerging awareness of early diagnosis is likely to drive the adoption of NIV masks and create significant opportunities in the market.
Moreover, respiratory illnesses are becoming more common in emerging economies, particularly in Asia Pacific, Latin America, and the Middle East, due to pollution, urbanization, and lifestyle changes. The Noninvasive therapies are becoming widely known in these areas, owing to which the use of NIV masks is likely to continue to propel during the forecast period.
Asia Pacific Non-Invasive Ventilation Masks Market Overview
The Asia Pacific noninvasive ventilation masks market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share of the market in the region during the forecast period. The noninvasive ventilation masks market in Asia Pacific is growing due to the surging utilization of NIV masks for the treatment of respiratory diseases such as obstructive sleep apnea, COPD, and neuromuscular disorders prevailing in the region. This growing use of NIV masks is expected to bring opportunities for market players to penetrate into emerging countries in Asia Pacific.
Asia Pacific Non-Invasive Ventilation Masks Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Non-Invasive Ventilation Masks Market Segmentation
The Asia Pacific non-invasive ventilation masks market is categorized into product, application, end user, and country.
By product, the Asia Pacific non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the Asia Pacific non-invasive ventilation masks market share in 2023.
- In terms of application, the Asia Pacific non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held the largest share of the Asia Pacific non-invasive ventilation masks market share in 2023.
- Based on end user, the Asia Pacific non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held the largest share of the Asia Pacific non-invasive ventilation masks market share in 2023.
- Based on country, the Asia Pacific non-invasive ventilation masks market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China segment held the largest share of Asia Pacific non-invasive ventilation masks market in 2023.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific non-invasive ventilation masks market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific non-invasive ventilation masks market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific non-invasive ventilation masks market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Asia Pacific Non-Invasive Ventilation Masks Market Landscape
5. Asia Pacific Non-Invasive Ventilation Masks Market - Key Market Dynamics
6. Asia Pacific Non-Invasive Ventilation Masks Market - Analysis
7. Asia Pacific Non-Invasive Ventilation Masks Market Analysis - by Product
8. Asia Pacific Non-Invasive Ventilation Masks Market Analysis - by Application
9. Asia Pacific Non-Invasive Ventilation Masks Market Analysis - by End User
10. Asia Pacific Non-Invasive Ventilation Masks Market - Country Analysis
11. Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
Some of the leading companies in the Asia Pacific Non-Invasive Ventilation Masks Market include:- Air Liquide Medical Systems
- Armstrong Medical Ltd
- Besmed Health Business Corp
- BMC Medical Co Ltd
- DeVilbiss Healthcare LLC
- Dimar S.P.A.
- Dragerwerk AG & Co KGaA
- Fisher & Paykel Healthcare Corp Ltd
- Hamilton Medical AG
- Hangzhou Formed Medical Devices Co., Ltd
- Intersurgical Ltd
- Koninklijke Philips NV
- Medline Industries LP
- ResMed Inc
- Sleepnet Corporation
- SunMed Group Holdings LLC ( AirLife)
- SURU INTERNATIONAL PVT. LTD.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 148 |
Published | March 2025 |
Forecast Period | 2023 - 2031 |
Estimated Market Value ( USD | $ 433.81 Million |
Forecasted Market Value ( USD | $ 719.68 Million |
Compound Annual Growth Rate | 6.5% |
Regions Covered | Asia Pacific |
No. of Companies Mentioned | 17 |